Characterization and functional role of voltage gated cation conductances in the glucagon-like peptide-1 secreting GLUTag cell line

Journal of Physiology

Volumn 563, Issue 1, 2005, Pages 161-175

  Reimann, F ^a   Maziarz, M ^b   Flock, G ^b   Habib, A M ^a   Drucker, D J ^b   Gribble, F M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (N ETHYL N PHENYLAMINO) 1,2 DIMETHYL 6 (METHYLAMINO)PYRIMIDINIUM CHLORIDE; CALCIUM CHANNEL L TYPE; CALCIUM ION; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; NIFEDIPINE; OMEGA CONOTOXIN GVIA; POTASSIUM ION; SODIUM ION; TETRODOTOXIN; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CELL LINE; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; CORRELATION FUNCTION; DNA MICROARRAY; ELECTROPHYSIOLOGY; GENE EXPRESSION; HORMONE RELEASE; HYPERPOLARIZATION; ION CONDUCTANCE; MOUSE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; SODIUM CURRENT; VOLTAGE CLAMP; WHOLE CELL; ACTION POTENTIAL AMPLITUDE; CALCIUM CONDUCTANCE; ENTEROENDOCRINE CELL; GLUTAG CELL LINE; IN VIVO STUDY; MICROARRAY ANALYSIS; POTASSIUM CONDUCTANCE; PROTEIN SECRETION; SODIUM CONDUCTANCE; VOLTAGE CLAMP TECHNIQUE; VOLTAGE GATED CATION CONDUCTANCE;

ANIMALS; CALCIUM; CATIONS, MONOVALENT; CELL LINE; ELECTRIC CONDUCTIVITY; ENTEROENDOCRINE CELLS; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; ION CHANNEL GATING; ION CHANNELS; MEMBRANE POTENTIALS; MICE; PEPTIDE FRAGMENTS; POTASSIUM; PROTEIN PRECURSORS; SODIUM;

EID: 14844321558     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.076414     Document Type: Article

References (30)

1. Anini Y & Brubaker PL (2003). Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells. Endocrinology 144, 3244-3250.
2. 2+ channels accounts for first-phase insulin secretion in mouse β-cells. Diabetes 51, S74-S82.
3. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL et al. (2002). Gut hormone PYY (3-36) physiologically inhibits food intake. Nature 418, 650-654.
4. 2+ channels and insulin-containing secretory granules and its significance for the initiation of exocytosis in mouse pancreatic B-cells. EMBO J 14, 50-57.
5. Brubaker PL, Schloos J & Drucker DJ (1998). Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line. Endocrinology 139, 4108-4114.
6. 2+ channels. Annu Rev Cell Dev Biol 16, 521-555.
7. Damholt AB, Buchan AM & Kofod H (1998). Glucagon-like-peptide-1 secretion from canine 1-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose. Endocrinology 139, 2085-2091.
8. Drucker DJ (2001). Minireview: the glucagon-like peptides. Endocrinology 142, 521-527.
9. Drucker DJ, Jin T, Asa SL, Young TA & Brubaker PL (1994). Activation of proglucagon gene transcription by protein kinase A in a novel mouse enteroendocrine cell line. Mol Endocrinol 8, 1646-1655.
10. Eissele R, Goke R, Willemer S, Harthus HP, Vermeer H, Arnold R et al. (1992). Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 22, 283-291.
11. Enc FY, Imeryuz N, Akin L, Turoglu T, Dede F, Haklar G et al. (2001). Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release. Am J Physiol 281, G752-G763.
12. Goldin AL (2001). Resurgence of sodium channel research. Annu Rev Physiol 63, 871-894.
13. Gopel S, Zhang Q, Eliasson L, Ma XS, Galvanovskis J, Kanno T et al. (2004). Capacitance measurements of exocytosis in mouse pancreatic alpha-, beta- and delta-cells within intact islets of Langerhans. J Physiol 556, 711-726.
14. Gribble FM, Williams L, Simpson AK & Reimann F (2003). A novel glucose-sensing mechanism contributing to Glucagon-Like Peptide-1 secretion from the GLUTag cell line. Diabetes 52, 1147-1154.
15. 2+ channels. J General Physiol 110, 217-228.
16. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260, 3440-3450.
17. Gutman GA, Chandy KG, Adelman JP, Aiyar J, Bayliss DA, Clapham DE et al. (2003). International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels. Pharmacol Rev 55, 583-586.
18. Hille B (2001). Ion Channels of Excitable Membranes. Sinauer Associates, Inc, Sunderland, MA.
19. Kieffer TJ & Habener JF (1999). The glucagon-like peptides. Endocr Rev 20, 876-913.
20. Miholic J, Orskov C, Holst JJ, Kotzerke J & Meyer HJ (1991). Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Dig Dis Sci 36 1361-1370.
21. Reimann F & Gribble FM (2002). Glucose sensing in GLP-1 secreting cells. Diabetes 51, 2757-2763.
22. Reimann F, Williams L, Silva Xavier G, Rutter GA & Gribble FM (2004). Glutamine potently stimulates glucagons-like peptide-1 secretion from GLUTag cells. Diabetologia 47, 1592-601.
23. Robinson RB & Siegelbaum SA (2003). Hyperpolarization-activated cation currents: from molecules to physiological function. Annu Rev Physiol 65, 453-480.
24. Rocca AS & Brubaker PL (1995). Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in fetal rat intestinal cultures. Endocrinology 136, 5593-5599.
25. Rocca AS & Brubaker PL (1999). Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 140, 1687-1694.
26. Rorsman P (1997). The pancreatic beta-cell as a fuel sensor: an electrophysiologist's viewpoint. Diabetologia 40, 487-495.
27. Rorsman P & Trube G (1986). Calcium and delayed potassium currents in mouse pancreatic beta-cells under voltage-clamp conditions. J Physiol 374, 531-550.
28. 2+ in two enteroendocrine cell lines, STC-1 and GLUTag. J Physiol 528, 165-176.
29. Stanley S, Wynne K & Bloom S (2004). Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide. Am J Physiol 286, G693-G697.
30. Zander M, Madsbad S, Madsen JL & Holst JJ (2002). Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 359, 824-830.